Combining TEMPI syndrome with hereditary thrombophilia
https://doi.org/10.30629/0023-2149-2020-98-4-300-302
Abstract
At the present time, there is a lot of information about clonal plasma cell processes, def ned as the plasma cell dyscrasiаs. We present a case of TEMPI syndrome, which was f rst detected in Russia and belongs to a rare form of plasma cell dyscrasia, with a description of the clinical symptoms, difficulties in differential diagnosis in the patient, and the genetic form of thrombophilia detected in this syndrome. The main manifestations of TEMPI syndrome are telangiectasias, erythrocytosis, monoclonal gammapathy, perinephric f uid collections, and intrapulmonary shunting. Currently, the mechanisms of the systemic effect of monoclonal secretion in this form of plasma cell dyscrasia have not yet been clearly established, and moreover, therapeutic approaches to its treatment have not been developed. The use of bortezomib in the onset of the disease and, further, as part of rotating courses with dexamethasone and cyclophosphane, gave a clinical and hematological effect.
About the Authors
V. I. ErshovRussian Federation
119991, Moscow.
I. Yu. Gadaev
Russian Federation
Igor Y. Gadaev — MD, Associate Professor, Department of Hospital Therapy No. 1 Clinical Medicine Institute N.V. Sklifosovsky.
119991, Moscow.
O. N. Antyufeeva
Russian Federation
119991, Moscow.
O. V. Bochkarnikova
Russian Federation
119991, Moscow.
I. Ya. Sokolova
Russian Federation
119991, Moscow.
D. A. Budanova
Russian Federation
119991, Moscow.
References
1. Hasan Bazari M.D., Eyal C.A., Douglas M.D., Raul N.U., M.D., Robert B.C. Case Records of the Massachusetts General Hospital (Case 23-2010). N. Engl. J. Med. 2010;363:463-75.
2. Sykes D.B., Schroyens W., O'Connell C. N. Engl. J. Med. 2011;365(5):475-477.
3. Roccaro E.A.M., Ghobrial I.M. Plasma Cell Dyscrasias. Cancer Treatment and Research. 169. 2016.
4. Kyle R.A., Greipp P.R. The laboratory investigation of monoclonal gammopathies. Mayo Clin. Proc. 1978;53(11):719-39.
5. Bridoux F., Leung N., Colin A.H. еt al. Diagnosis of monoclonal gammopathy of renal Signif cance. 2015 International Society of Nephrology.
6. Lipsker D. Monoclonal gammopathy of cutaneous significance: review of a relevant concept. J. Eur. Acad. Dermatol. Venereol. 2017;31(1):45-52.
7. Dispenzieri A. POEMS syndrome: update on diagnosis, risk-stratification, and management. Am. J. Hematol. 2015;90(10):951-62.
8. Simon A., Asli B., Braun-Falco M., De Koning H. Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68(5):562-8.
9. Sykes D.B., Schroyens W., O'Connell C. The TEMPI syndrome — a novel multisystem disease. N. Engl. J. Med. 2011;365(5):475-7.
10. Merlini G.L., Stone M.J. Dangerous small B-cell clones. Blood. 2006;108(8):2520-2530.
Review
For citations:
Ershov V.I., Gadaev I.Yu., Antyufeeva O.N., Bochkarnikova O.V., Sokolova I.Ya., Budanova D.A. Combining TEMPI syndrome with hereditary thrombophilia. Clinical Medicine (Russian Journal). 2020;98(4):300-302. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-4-300-302